Contracting and Reimbursement
- Simplify pricing and coding
- Effectively manage and share formulary changes
- Evaluate specialty pharmacy performance
- Validate formulary and medical benefit contracts
Accurately Identify Patients and Their HCPs, Even for Rare and Hard-to-Diagnose Conditions
MMIT’s HCP and Patient Targeting Solution is powered by NorstellaLinQ, the industry’s first and only fully integrated data asset created by MMIT’s parent company Norstella.
Using structured and unstructured data like electronic medical records, open and closed claims, and lab orders and results, we help you pinpoint hard-to-reach patients and their treating providers.
Learn More
Patient Finding
Identify patients and their treating providers at the right time in the patient journey.
Market Sizing
Understand the true prevalence of rare and hard-to-diagnose conditions.
Risk Stratification
Hyper-segment patients using clinical notes, lab results and other real-world data.
Patient Journey
Correlate treatment patterns with HCP sentiment and behavior, payer coverage, site-of-care trends and other factors.
How We Can Help
NorstellaLinQ brings together open and closed claims, lab results, electronic medical records, and payer intelligence data.
Our tech, data, clinical, and pharma experts tailor the data to your needs to ensure success.
Our harmonized, linked, longitudinal data is ready to use.
Outputs can be delivered in a tailored solution that meets your needs.
WHATS NEW
Keep Up-to-Date With Key Insights From MMIT
NorstellaLinQ
The biopharma industry’s first fully integrated data asset is paving the way for breakthroughs in commercialization.
Unlocking Value Potential for a Client’s Rare Disease Treatment
Learn how MMIT, powered by NorstellaLinQ, translated complex real-world data into actionable strategies to help a pharmaceutical manufacturer identify patients early in the treatment journey for a rare disease.
Complex Cohort Identification Fuels Real-Time HCP Targeting
Learn how MMIT, powered by NorstellaLinQ, helped an oncology manufacturer comb through unstructured clinical notes and surface ten times as many patients as with claims data alone.
RELATED SOLUTIONS
Solutions to Support Your Strategy
RWD Visualizations
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
RWD Insights
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.
Unstructured Data
MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.